Genetron Holdings Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GTH research report →
Companywww.genetronhealth.com
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors.
- CEO
- Sizhen Wang
- IPO
- 2020
- Employees
- 993
- HQ
- Beijing, CN
Price Chart
Valuation
- Market Cap
- $127.29M
- P/E
- -0.96
- P/S
- 1.33
- P/B
- 1.55
- EV/EBITDA
- -1.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.25%
- Op Margin
- -97.07%
- Net Margin
- -135.84%
- ROE
- -100.92%
- ROIC
- -88.13%
Growth & Income
- Revenue
- $650.71M · 22.32%
- Net Income
- $-883,889,000 · -101.62%
- EPS
- $-28.53 · -499.37%
- Op Income
- $-631,620,000
- FCF YoY
- 11.10%
Performance & Tape
- 52W High
- $4.05
- 52W Low
- $2.08
- 50D MA
- $3.87
- 200D MA
- $3.33
- Beta
- 0.50
- Avg Volume
- 51.86K
Get TickerSpark's AI analysis on GTH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GTH Coverage
We haven't published any research on GTH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GTH Report →